Ascidian Therapeutics
1 follower
‌
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.
Industries
Headquarters
Employees
Links
Org chart
Akiko Noma
Director In Research
Carrie Wager
Svp, Head Of Operations
Daniel Rosan
CFO and CBO
Michael Ehlers
Founder, President, And Chief Executive Officer
Robert Bell
Chief Scientific Officer
Elana Gonsalves, SHRM-CP
Senior Manager Human Resources
Alia Rashid
Vice President, Clinical Development
Carmen Jacome
Vice President, Program Management
Conor Delaney
Research Engineer II
